Literature DB >> 18221747

Determination of ofloxacin enantiomers in sewage using two-step solid-phase extraction and liquid chromatography with fluorescence detection.

Bing Shao1, Xiaojie Sun, Jing Zhang, Jianying Hu, Huiru Dong, Yi Yang.   

Abstract

A robust analytical method has been developed and validated for the trace analysis of ofloxacin enantiomers in sewage using two-step solid-phase extraction purification and liquid chromatography with fluorescence detection (LC-FL). Ofloxacin enantiomers were separated on an Aglient TC-C-18 column using MeOH-water containing 4mmol/L CuSO4 and 5mmol/L l-isoleucine as mobile phase. The ofloxacin enantiomers were first extracted by a weak cation-exchange resin (WCX) and eluted with acidified MeOH (0.5% formic acid), then further purified by mixed mode of anion-exchange resin (MAX), resulting in ofloxacin recoveries generally above 95%. The limit of quantification was 0.08microg/L for each enantiomer. No significant matrix effect was found during the analytical procedure and standard solution calibration curves could be used for quantification. Total concentrations of both enantiomers in real sewage samples based on LC-FL method were consistent with those obtained upon liquid chromatography using tandem mass spectrometry (LC-MS/MS) method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18221747     DOI: 10.1016/j.chroma.2007.12.073

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Removal of genotoxicity in chlorinated secondary effluent of a domestic wastewater treatment plant during dechlorination.

Authors:  Qian-Yuan Wu; Yi Li; Hong-Ying Hu; Ya-Nan Ding; Huang Huang; Feng-Yun Zhao
Journal:  Environ Sci Pollut Res Int       Date:  2011-06-03       Impact factor: 4.223

2.  Simultaneous voltammetric determination of nitazoxanide and ofloxacin in pharmaceutical formulation.

Authors:  Shital Gandhi; V Mehta; Sadhana Rajput
Journal:  Indian J Pharm Sci       Date:  2011-09       Impact factor: 0.975

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.